검색결과 : 3건
| No. | Article |
|---|---|
| 1 |
A STING-activating nanovaccine for cancer immunotherapy Luo M, Wang H, Wang ZH, Cai HC, Lu ZG, Li Y, Du MJ, Huang G, Wang CS, Chen X, Porembka MR, Lea J, Frankel AE, Fu YX, Chen ZJJ, Gao JM Nature Nanotechnology, 12(7), 648, 2017 |
| 2 |
GMP production and characterization of the bivalent anti-human T cell immunotoxin, A-dmDT390-bisFv(UCHTl) for phase I/II clinical trials Woo JH, Liu JS, Kang SH, Singh R, Park SK, Su YP, Ortiz J, Neville DM, Willingham MC, Frankel AE Protein Expression and Purification, 58(1), 1, 2008 |
| 3 |
Expression and purification of the recombinant diphtheria fusion toxin DT(388)IL3 for phase I clinical trials Urieto JO, Liu TF, Black JH, Cohen KA, Hall PD, Willingham MC, Pennell LK, Hogge DE, Kreitman RJ, Frankel AE Protein Expression and Purification, 33(1), 123, 2004 |